Riha Vaidya

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Fred Hutch Cancer Center, Flatiron Health (United States)

Economics, Econometrics and FinanceMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Papers

Driven by 21 papers — median percentile 0. Top paper: “Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings”.

Association of Patient Demographic Characteristics and Insurance Status With Survival in Cancer Randomized Clinical Trials With Positive Findings

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3842

N/A

3.0DataRank · unranked

48 citations

Charles D. Blanke, Michael LeBlanc, William E. Barlow, Riha Vaidya, Scott D. Ramsey +2 more

Socioeconomic Deprivation and Health Care Use in Patients Enrolled in SWOG Cancer Clinical Trials

JAMA Network Open(2024)10.1001/jamanetworkopen.2024.4008

N/A

0.396DataRank · unranked

13 citations

Riha Vaidya, Cathee Till, William E. Barlow, Mike LeBlanc, Scott D. Ramsey +2 more

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

JCO Clinical Cancer Informatics(2023)10.1200/cci.22.00165

N/A

0.336DataRank · unranked

4 citations

Weijia Fan, Aijin Wang, Riha Vaidya, Mary W. Redman, Scott Gettinger +5 more

The Medicaid expansion of the Affordable Care Act and participation of patients with Medicaid in cancer clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6505

N/A

0.208DataRank · unranked

3 citations

Hong Xiao, Riha Vaidya, Dawn L. Hershman, Joseph M. Unger

S2303: phase II/III trial of paclitaxel + ramucirumab ± nivolumab in gastric and esophageal adenocarcinoma (PARAMUNE)

Future Oncology(2025)10.1080/14796694.2025.2485020

N/A

0.176DataRank · unranked

2 citations

Sarah Colby, Paul E. Oberstein, Dan G. Duda, Robin Park, Rajiv Agarwal +12 more

Trends in obesity among patients registered to SWOG cancer clinical treatment trials.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.29_suppl.126

N/A

0.165DataRank · unranked

2 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016

JAMA Network Open(2022)10.1001/jamanetworkopen.2022.34445

N/A

0DataRank · unranked

10 citations

Cathee Till, Heather Greenlee, Dawn L. Hershman, Joseph M. Unger, Riha Vaidya

Socioeconomic deprivation and patient-reported outcomes in symptom management trials for patients with breast cancer.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.158

N/A

0DataRank · unranked

2 citations

Cathee Till, N. Lynn Henry, Michael Fisch, Dawn L. Hershman, Joseph M. Unger +1 more

Survival outcomes by insurance status for patients with cancer ages 18-64 and 65 or older treated in clinical trials.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.28_suppl.154

N/A

0DataRank · unranked

1 citations

Anna Moseley, Riha Vaidya, Hong Xiao, Michael LeBlanc, Dawn L. Hershman +1 more

Representativeness of patients enrolled in the Lung Cancer Master Protocol (Lung-MAP).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.6543

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Qian Lü, Katherine Minichiello, Roy S. Herbst, David R. Gandara +14 more

Assessment of financial screening and navigation capabilities at National Cancer Institute community oncology clinics

JNCI Cancer Spectrum(2023)10.1093/jncics/pkad055

N/A

0DataRank · unranked

15 citations

Kate Watabayashi, Debbie Delaney, Ruth C. Carlos, Shelby L. Langer, Joseph M. Unger +6 more

Preference-weighted quality of life: Findings from the Selenium and Vitamin E Cancer Prevention Trial (SELECT).

Journal of Clinical Oncology(2021)10.1200/jco.2020.39.28_suppl.144

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, Joseph M. Unger, Dawn L. Hershman, Daniel Maeng +2 more

Examining uptake of electronic patient reported outcomes (ePRO) in a prospective study of immune-related adverse events (IR-AEs).

JCO Oncology Practice(2023)10.1200/op.2023.19.11_suppl.368

N/A

0DataRank · unranked

2 citations

Amy K. Darke, Krishna S. Gunturu, Dawn L. Hershman, Michael Fisch, N. Lynn Henry +2 more

Access to urologists for participation in research: An analysis of NCI's Community Oncology Research Program landscape survey

Contemporary Clinical Trials Communications(2022)10.1016/j.conctc.2022.100981

N/A

0DataRank · unranked

3 citations

Riha Vaidya, Joseph M. Unger, Kelly Stratton, Jessie Gills, Peter J. Van Veldhuizen +9 more

Association of measures of socioeconomic deprivation with healthcare utilization in elderly patients enrolled in SWOG cancer clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.6527

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Cathee Till, William E. Barlow, Michael LeBlanc, Scott D. Ramsey +2 more

The association of sociodemographic variables with smoking prevalence in patients enrolled on clinical trials.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.e13595

Top 100%

0DataRank

Top 100%0 citations

Riha Vaidya, Cathee Till, Kimlin Ashing, Graham Warren, Dawn L. Hershman +13 more

Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0255

N/A

0DataRank · unranked

0 citations

Joseph M. Unger, Rohit Loomba, Jessica Hwang, Rashmi Chugh, Monica A. Tincopa +4 more

Feasibility of a digital medicine program in optimizing opioid pain control in cancer patients (SWOG S1916).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps12126

N/A

0DataRank · unranked

0 citations

Riha Vaidya, Amy K. Darke, Joseph M. Unger, Mina S. Sedrak, Barbara Segarra-Vázquez +9 more

Smoking prevalence and association with sociodemographic variables in cancer clinical trial participants

Cancer(2024)10.1002/cncr.35560

N/A

0DataRank · unranked

2 citations

Cathee Till, Riha Vaidya, Kimlin Ashing, Graham Warren, Virginia Sun +11 more

The cost of doing business: Drug costs in federally sponsored cancer clinical trials.

JCO Oncology Practice(2024)10.1200/op.2024.20.10_suppl.10

N/A

0DataRank · unranked

2 citations

Hong Xiao, Riha Vaidya, Sara Ashley Threlkel, Matthew Chansky, Allison Hayes +3 more

S2207: RANDOMIZED PHASE II STUDY OF THE ADDITION OF TARGETED AGENTS TO TAFASITAMAB‐LENALIDOMIDE IN TRANSPLANT INELIGIBLE PATIENTS WITH RELAPSED/REFRACTORY LBCL

Hematological Oncology(2023)10.1002/hon.3166_ot22

N/A

0DataRank · unranked

1 citations

Patrick M. Reagan, H. Li, Hayder Saeed, Riha Vaidya, Joseph M. Unger +5 more

Riha Vaidya

Indexed papers

Top data-sharing exemplar

Papers